Literature DB >> 24055422

Effects of myogenin on muscle fiber types and key metabolic enzymes in gene transfer mice and C2C12 myoblasts.

Lin-Na Zhu1, Yang Ren, Jing-Qing Chen, Yi-Zhen Wang.   

Abstract

Skeletal muscle fiber type composition is one of the important factors influencing muscle growth and meat quality. As a member of the myogenic transcription factors, myogenin (MyoG) is required for embryonic myoblast differentiation, but the expression of MyoG continues in mature muscle tissue of adult animals, especially in oxidative metabolic muscle, which suggests that MyoG may play a more extended role. Therefore, using MyoG gene transfer mice and C2C12 myoblasts as in vivo and in vitro models, respectively, we elected to study the role of MyoG in muscle fiber types and oxidative metabolism by using overexpression and siRNA suppression strategies. The overexpression of MyoG by DNA electroporation in mouse gastrocnemius muscle had no significant effect on fiber type composition but upregulated the mRNA expression (P<0.01) and enzyme activity (P<0.05) of oxidative succinic dehydrogenase (SDH). In addition, downregulation of the activity of the glycolytic enzymes lactate dehydrogenase (LDH, P<0.05) and pyruvate kinase (PK, P<0.05) was observed in MyoG gene transfer mice. In vitro experiments verified the results obtained in mice. Stable MyoG-transfected differentiating C2C12 cells showed higher mRNA expression levels of myosin heavy chain (MyHC) isoform IIX (P<0.01) and SDH (P<0.05), while the LDH mRNA was attenuated. The enzyme activities of SDH (P<0.01) and LDH (P<0.05) were similarly altered at the mRNA level. When MyoG was knocked down in C2C12 cells, MyHC IIX expression (P<0.05) was decreased, but the mRNA level (P<0.05) and the enzyme activity (P<0.05) of SDH were increased. Downregulating MyoG also increased the activity of the glycolytic enzymes PK (P<0.05) and hexokinase (HK, P<0.05). Based on those results, we concluded that MyoG barely changes the MyHC isoforms, except MyHC IIX, in differentiating myoblasts but probably influences the shift from glycolytic metabolism towards oxidative metabolism both in vivo and in vitro. These results contribute to further understand the role of MyoG in skeletal muscle energy metabolism and also help to explore the key genes that regulate meat quality.
© 2013.

Entities:  

Keywords:  HK; LDH; Muscle fiber types; MyHC; MyoG; Myogenin; Oxidative metabolism; PK; SDH; hexokinase; lactate dehydrogenase; myogenin; myosin heavy chain; pyruvate kinase; succinic dehydrogenase

Mesh:

Substances:

Year:  2013        PMID: 24055422     DOI: 10.1016/j.gene.2013.09.028

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  14 in total

Review 1.  Gene therapy for inherited muscle diseases: where genetics meets rehabilitation medicine.

Authors:  Robynne Braun; Zejing Wang; David L Mack; Martin K Childers
Journal:  Am J Phys Med Rehabil       Date:  2014-11       Impact factor: 2.159

2.  Ethanol-Impaired Myogenic Differentiation is Associated With Decreased Myoblast Glycolytic Function.

Authors:  Danielle E Levitt; Naveena Chalapati; Matthew J Prendergast; Liz Simon; Patricia E Molina
Journal:  Alcohol Clin Exp Res       Date:  2020-10-03       Impact factor: 3.455

3.  The regulation of skeletal muscle fiber-type composition by betaine is associated with NFATc1/MyoD.

Authors:  Jingjing Du; Linyuan Shen; Peiwen Zhang; Zhendong Tan; Xiao Cheng; Jia Luo; Xue Zhao; Qiong Yang; Hao Gu; An'an Jiang; Jideng Ma; Qianzi Tang; Long Jin; Surong Shuai; Mingzhou Li; Yanzhi Jiang; Guoqing Tang; Lin Bai; Xuewei Li; Jinyong Wang; Shunhua Zhang; Li Zhu
Journal:  J Mol Med (Berl)       Date:  2018-06-06       Impact factor: 4.599

4.  Short Communication: Supplementation with calcium butyrate causes an increase in the percentage of oxidative fibers in equine gluteus medius muscle.

Authors:  Nicolas I Busse; Madison L Gonzalez; Ashley L Wagner; Sally E Johnson
Journal:  J Anim Sci       Date:  2022-08-01       Impact factor: 3.338

5.  Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.

Authors:  Wenjia Lou; Christian A Reynolds; Yiran Li; Jenney Liu; Maik Hüttemann; Michael Schlame; David Stevenson; Douglas Strathdee; Miriam L Greenberg
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-22       Impact factor: 4.698

6.  Kinin-B2 Receptor Activity in Skeletal Muscle Regeneration and Myoblast Differentiation.

Authors:  Janaina M Alves; Antonio H Martins; Claudiana Lameu; Talita Glaser; Nawal M Boukli; Vinicius Bassaneze; Rafael Dariolli; Isis C Nascimento; Poliana C M Martins; Héllio D N de Souza; José Eduardo Krieger; Dulce E Casarini; Vicencia M Sales; João B Pesquero; Henning Ulrich
Journal:  Stem Cell Rev Rep       Date:  2019-02       Impact factor: 5.739

7.  Agonist muscle adaptation accompanied by antagonist muscle atrophy in the hindlimb of mice following stretch-shortening contraction training.

Authors:  Erik P Rader; Marshall A Naimo; James Ensey; Brent A Baker
Journal:  BMC Musculoskelet Disord       Date:  2017-02-02       Impact factor: 2.362

8.  Mild Hyperthermia-Induced Myogenic Differentiation in Skeletal Muscle Cells: Implications for Local Hyperthermic Therapy for Skeletal Muscle Injury.

Authors:  Hojun Lee; Seung-Jun Choi
Journal:  Oxid Med Cell Longev       Date:  2018-06-27       Impact factor: 6.543

9.  Nerve Growth Factor Promotes Angiogenesis and Skeletal Muscle Fiber Remodeling in a Murine Model of Hindlimb Ischemia.

Authors:  Yong-Peng Diao; Feng-Kui Cui; Sheng Yan; Zuo-Guan Chen; Li-Shan Lian; Li-Long Guo; Yong-Jun Li
Journal:  Chin Med J (Engl)       Date:  2016-02-05       Impact factor: 2.628

10.  Characterization of the promoter region of the bovine SIX1 gene: Roles of MyoD, PAX7, CREB and MyoG.

Authors:  Da-Wei Wei; Xue-Yao Ma; Song- Zhang; Jie-Yun Hong; Lin-Sheng Gui; Chu-Gang Mei; Hong-Fang Guo; Li- Wang; Yue- Ning; Lin-Sen Zan
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.